Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles.
St Jean, D.J., Ashton, K.S., Bartberger, M.D., Chen, J., Chmait, S., Cupples, R., Galbreath, E., Helmering, J., Hong, F.T., Jordan, S.R., Liu, L., Kunz, R.K., Michelsen, K., Nishimura, N., Pennington, L.D., Poon, S.F., Reid, D., Sivits, G., Stec, M.M., Tadesse, S., Tamayo, N., Van, G., Yang, K.C., Zhang, J., Norman, M.H., Fotsch, C., Lloyd, D.J., Hale, C.
J.Med.Chem.